Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study
about
Plitidepsin: design, development, and potential place in therapy.Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.Searching for aurora in the night of sarcoma phase II trials: isn't it time to move to second gear?Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.
P2860
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@ast
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@en
type
label
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@ast
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@en
prefLabel
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@ast
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@en
P2093
P2860
P356
P1433
P1476
Aplidin in patients with advan ...... roup Single-Arm Phase II study
@en
P2093
A Italiano
A Le Cesne
C Chevreau
M Toulmonde
S Piperno-Neumann
P2860
P304
P356
10.1093/ANNONC/MDV195
P577
2015-06-03T00:00:00Z